The Feasibility and Efficacy of an Extremely Brief Mindfulness Practice

December 10, 2018 updated by: Duke University
This study will assess the efficacy of brief mindfulness practices on improving mental health in adults who are currently in treatment for mental health concerns. From online instructional videos, each participant will learn a thirty-second or three-minute mindfulness practice that is to be performed at least three times daily over two weeks.

Study Overview

Detailed Description

Mindfulness meditation and mindfulness-based therapies have been shown to improve many aspects of psychological functioning in individuals with mental health problems.

The purpose of this study is to assess the feasibility, acceptability, and efficacy in improving mental health of brief mindfulness practices in adults currently in treatment for mental health concerns. The entire study will be administered online. From online instructional videos, each participant will learn a thirty-second or three-minute mindfulness practice that is to be performed at least three times daily over two weeks. A delayed-treatment control group will begin the intervention after a two-week waiting period.

Study Type

Interventional

Enrollment (Actual)

42

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • North Carolina
      • Durham, North Carolina, United States
        • Duke Office of Clinical Research REDCap Online Data Collection Software

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Regular internet access
  • Able to listen to audio files
  • Currently receiving outpatient care
  • No change in type of psychotherapy during the past month
  • If taking medications, a stable, unchanging prescription for the previous month
  • Willingness to sign release of mental health care information
  • Capacity to provide informed consent

Exclusion Criteria:

  • Does not speak and read English

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Wait List Control
Participants receive daily email surveys for two weeks before being given access to the brief-mindfulness-practice training materials.
Experimental: Thirty-Second Mindfulness Practice
Participants watch a ten minute mindfulness training video then are given electronic access to an audio recording of guidance for a thirty-second mindfulness meditation practice. Participants are asked to complete this practice using the audio-recorded guidance at least three times a day for two weeks. Participants are sent daily emails that include reminders to complete the practice and a link to a brief online survey.
Active Comparator: Three-Minute Mindfulness Practice
Participants watch a ten minute mindfulness training video then are given electronic access to an audio recording of guidance for a three minute mindfulness meditation practice. Participants are asked to complete this practice using the audio-recorded guidance at least three times a day for two weeks. Participants are sent daily emails that include reminders to complete the practice and a link to a brief online survey.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Change in trait mindfulness as measured by the Five Facet Mindfulness Questionnaire (Baer et al. 2006)
Time Frame: Baseline, 2 weeks and 4 weeks
Baseline, 2 weeks and 4 weeks
Change in perceived stress as measured by the Perceived Stress Scale (Cohen, Kamarck, & Mermelstein, 1983)
Time Frame: Baseline, 2 weeks and 4 weeks
Baseline, 2 weeks and 4 weeks
Change in anxiety symptoms as measured by the GAD-7, Generalized Anxiety Disorder Scale (Spitzer, Kroenke, Williams, & Löwe, 2006)
Time Frame: Baseline, 2 weeks and 4 weeks
Baseline, 2 weeks and 4 weeks
Change in mood as measured by the Positive and Negative Affect Schedule (Watson, Clark, & Tellegen, 1988)
Time Frame: Baseline, 2 weeks and 4 weeks
Baseline, 2 weeks and 4 weeks
Change in quality of life as measured by the Medical Outcomes Study 36-Item Short-Form Health Survey (Ware & Sherbourne, 1992)
Time Frame: Baseline, 2 weeks and 4 weeks
Baseline, 2 weeks and 4 weeks
Change in depression symptoms as measured by the PHQ-8, Patient Health Questionnaire - depression module (Spitzer, Kroenke, & Williams, 1999)
Time Frame: Baseline, 2 weeks and 4 weeks
Baseline, 2 weeks and 4 weeks

Secondary Outcome Measures

Outcome Measure
Time Frame
Group difference in intervention's acceptability as measured by qualitative questions
Time Frame: 1 week into intervention
1 week into intervention
Group difference in adherence as measured by frequency of daily brief mindfulness practice use
Time Frame: Daily for two weeks of intervention
Daily for two weeks of intervention
Group difference in continued brief mindfulness practice use as measured by follow-up question
Time Frame: Follow up (two weeks after intervention)
Follow up (two weeks after intervention)
Change in daily mood measured on a visual analogue scale
Time Frame: Daily for two weeks of intervention
Daily for two weeks of intervention
Change in daily stress level measured on a visual analogue scale
Time Frame: Daily for two weeks of intervention
Daily for two weeks of intervention
Change in empathy as measured by the Interpersonal Reactivity Index (Davis, 1980) and four questions adapted from Hawk, Fischer and Van Kleef, (2011)
Time Frame: Baseline, 2 weeks and 4 weeks
Baseline, 2 weeks and 4 weeks
Change in perspective taking as measured by questions adapted from Hawk, Fischer and Van Kleef, (2011)
Time Frame: Baseline, 2 weeks and 4 weeks
Baseline, 2 weeks and 4 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Moria Smoski, Ph.D, Duke University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

November 1, 2016

Primary Completion (Actual)

September 9, 2018

Study Completion (Actual)

September 9, 2018

Study Registration Dates

First Submitted

November 1, 2016

First Submitted That Met QC Criteria

November 1, 2016

First Posted (Estimate)

November 2, 2016

Study Record Updates

Last Update Posted (Actual)

December 12, 2018

Last Update Submitted That Met QC Criteria

December 10, 2018

Last Verified

December 1, 2018

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • Pro00072981

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe